Loading...
XNASHCAT
Market cap451mUSD
Jan 03, Last price  
7.42USD
1D
1.16%
1Q
-3.64%
IPO
-80.63%
Name

Health Catalyst Inc

Chart & Performance

D1W1MN
XNAS:HCAT chart
P/E
—
P/S
1.53
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
15.23%
Rev. gr., 5y
21.33%
Revenues
296m
+7.13%
73,081,000112,574,000154,941,000188,845,000241,926,000276,236,000295,938,000
Net income
-118m
L-14.01%
-47,035,000-61,984,000-60,096,000-115,017,000-153,210,000-137,403,000-118,147,000
CFO
-33m
L-6.21%
-36,829,000-40,296,000-32,184,000-26,148,000-23,123,000-35,270,000-33,080,000
Earnings
Feb 20, 2025

Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
URL
https://www.healthcatalyst.com/
IPO date
Jul 25, 2019
Employees
1,200
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
295,938
7.13%
276,236
14.18%
Cost of revenue
380,612
367,944
Unusual Expense (Income)
NOPBT
(84,674)
(91,708)
NOPBT Margin
Operating Taxes
356
(4,280)
Tax Rate
NOPAT
(85,030)
(87,428)
Net income
(118,147)
-14.01%
(137,403)
-10.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,808)
(4,424)
BB yield
0.35%
0.77%
Debt
Debt current
6,716
3,434
Long-term debt
266,744
265,991
Deferred revenue
77
105
Other long-term liabilities
74
121
Net debt
(44,268)
(94,065)
Cash flow
Cash from operating activities
(33,080)
(35,270)
CAPEX
(1,236)
(17,414)
Cash from investing activities
20,293
(39,021)
Cash from financing activities
2,730
(2,613)
FCF
(82,083)
(85,565)
Balance
Cash
317,728
363,490
Long term investments
Excess cash
302,931
349,678
Stockholders' equity
366,919
425,010
Invested Capital
316,565
323,532
ROIC
ROCE
EV
Common stock shares outstanding
56,418
54,080
Price
9.26
-12.89%
10.63
-73.17%
Market cap
522,434
-9.12%
574,868
-69.45%
EV
478,166
480,803
EBITDA
(42,451)
(43,411)
EV/EBITDA
Interest
7,287
1,678
Interest/NOPBT